Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Kevin K Dobbin"'
Autor:
Lindsey A Sellers, Kathryn M Fitton, Margaret F Segovia, Christy C Forehand, Kevin K Dobbin, Andrea Sikora Newsome
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
Objectives: Concern for late detection of bacterial pathogens is a barrier to early de-escalation efforts. The purpose of this study was to assess blood, respiratory and urine culture results at 72 h to test the hypothesis that early negative culture
Externí odkaz:
https://doaj.org/article/8e385f111e554d828e6ee5ebbe7bc735
Autor:
Deli Liu, Huan Xiong, Angela E Ellis, Nicole C Northrup, Kevin K Dobbin, Dong M Shin, Shaying Zhao
Publikováno v:
PLoS Genetics, Vol 11, Iss 6, p e1005277 (2015)
Spontaneous canine head and neck squamous cell carcinoma (HNSCC) represents an excellent model of human HNSCC but is greatly understudied. To better understand and utilize this valuable resource, we performed a pilot study that represents its first g
Externí odkaz:
https://doaj.org/article/4d9f497564cf4607be98d1e5a38f2dfa
Autor:
Joshua Watson, Tianfang Wang, Kun-Lin Ho, Yuan Feng, Tanakamol Mahawan, Kevin K. Dobbin, Shaying Zhao
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-18 (2023)
Abstract Background About 20% of breast cancers in humans are basal-like, a subtype that is often triple-negative and difficult to treat. An effective translational model for basal-like breast cancer is currently lacking and urgently needed. To deter
Externí odkaz:
https://doaj.org/article/07da5cd758a8405d823f093186adb7c0
Autor:
Asma M. Ali, Anne H. Gaglioti, Rebecca H. Stone, Natalie D. Crawford, Kevin K. Dobbin, Lokesh Guglani, Henry N. Young
Publikováno v:
Journal of Primary Care & Community Health, Vol 13 (2022)
Objectives: To describe access to and use of prescription asthma medications, and to assess factors associated with asthma exacerbation, healthcare utilization, and health status among asthma patients treated at Federally Qualified Health Centers. Me
Externí odkaz:
https://doaj.org/article/b3b457c866484f8ea211a6b1af39ebb8
Publikováno v:
Family Practice. 40:261-267
Background Individual symptoms and signs of infectious mononucleosis (IM) are of limited value for diagnosis. Objective To develop and validate risk scores based on signs and symptoms with and without haematologic parameters for the diagnosis of IM.
Supplementary Data from How Large a Training Set is Needed to Develop a Classifier for Microarray Data?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885037bd3c8e2c83ecbb13248c03caf3
https://doi.org/10.1158/1078-0432.22441452
https://doi.org/10.1158/1078-0432.22441452
Purpose: A common goal of gene expression microarray studies is the development of a classifier that can be used to divide patients into groups with different prognoses, or with different expected responses to a therapy. These types of classifiers ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49c559e8ba4f1734f333e56ee8617f2
https://doi.org/10.1158/1078-0432.c.6518520.v1
https://doi.org/10.1158/1078-0432.c.6518520.v1
Autor:
Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
There is growing recognition that immunotherapy is likely to significantly improve health outcomes for cancer patients in the coming years. Currently, while a subset of patients experience substantial clinical benefit in response to different immunot
Externí odkaz:
https://doaj.org/article/748ae8e988824512bc03a5774ee55e31
Autor:
Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, there have been many clinical successes using checkpoint receptor blockade, including T cell inhibitory receptors such as cytotoxic T-lympho
Externí odkaz:
https://doaj.org/article/4a82936ee76d4634b39c83d24e2dece9
Autor:
Xiao Song, Kevin K. Dobbin
Publikováno v:
Biostatistics
Summary We consider evaluating new or more accurately measured predictive biomarkers for treatment selection based on a previous clinical trial involving standard biomarkers. Instead of rerunning the clinical trial with the new biomarkers, we propose